Breaking News Instant updates and real-time market news.

PLXP

PLx Pharma

$19.58 /

-0.36 (-1.81%)

, RAD

Rite Aid

$14.86 /

+0.25 (+1.71%)

16:36
07/26/21
07/26
16:36
07/26/21
16:36

PLx Pharma's Vazalore to launch in over 2,400 Rite Aid stores in August

PLx Pharma (PLXP) announced that three stock-keeping units of VAZALORE, "the first and only U.S. Food and Drug Administration approved liquid-filled aspirin capsules," said the company, will be available in over 2,400 Rite Aid (RAD) stores later in August. "Our commercial launch plans are well under way, and we are delighted that Rite Aid is preparing its stores for VAZALORE later this summer. We look forward to adding Rite Aid to the growing number of retail pharmacy leaders that are providing access to this innovative aspirin therapy," stated Natasha Giordano, Chief Executive Officer of PLx.

PLXP

PLx Pharma

$19.58 /

-0.36 (-1.81%)

RAD

Rite Aid

$14.86 /

+0.25 (+1.71%)

  • 06

    Aug

  • 03

    Mar

PLXP PLx Pharma
$19.58 /

-0.36 (-1.81%)

07/20/21 JMP Securities
PLx Pharma price target raised to $21 from $12 at JMP Securities
04/09/21 Oppenheimer
PLx Pharma initiated with an Outperform at Oppenheimer
04/09/21 Oppenheimer
PLx Pharma initiated with an Outperform at Oppenheimer
03/01/21 JMP Securities
PLx Pharma price target raised to $12 from $9 at JMP Securities
RAD Rite Aid
$14.86 /

+0.25 (+1.71%)

06/25/21
Fly Intel: Top five analyst downgrades
06/25/21 JPMorgan
Rite Aid downgraded to Underweight from Neutral at JPMorgan
06/25/21 Deutsche Bank
Rite Aid price target lowered to $13 from $18 at Deutsche Bank
06/22/21 Deutsche Bank
Rite Aid price target lowered to $18 from $27 at Deutsche Bank

TODAY'S FREE FLY STORIES

Earnings
Iqvia reports Q3 EPS $2.17, consensus $2.12 » 07:04
10/21/21
10/21
07:04
10/21/21
07:04
IQV

Iqvia

$251.71 /

+2.65 (+1.06%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IQV Iqvia
$251.71 /

+2.65 (+1.06%)

IQV Iqvia
$251.71 /

+2.65 (+1.06%)

10/15/21 KeyBanc
Iqvia price target raised to $270 from $260 at KeyBanc
09/10/21 Argus
Iqvia price target raised to $290 from $260 at Argus
08/04/21 Credit Suisse
Iqvia assumed with an Outperform at Credit Suisse
07/28/21 Piper Sandler
Iqvia price target raised to $235 from $204 at Piper Sandler
IQV Iqvia
$251.71 /

+2.65 (+1.06%)

Hot Stocks
KeyCorp sees long-term ROTCE 16%-19%, cash efficiency ratio 54%-56% » 07:03
10/21/21
10/21
07:03
10/21/21
07:03
KEY

KeyCorp

$23.72 /

+0.52 (+2.24%)

Sees positive operating…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

10/11/21 Jefferies
KeyCorp price target raised to $27 from $25 at Jefferies
07/19/21 Odeon Capital
KeyCorp downgraded to Hold from Buy at Odeon Capital
07/16/21 Citi
KeyCorp assumed with a Neutral at Citi
07/06/21 Keefe Bruyette
KeyCorp assumed with a Market Perform at Keefe Bruyette
KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

Hot Stocks
Bristol-Myers' Opdivo combination approved in Europe for adenocarcinoma » 07:03
10/21/21
10/21
07:03
10/21/21
07:03
BMY

Bristol-Myers

$58.07 /

+0.48 (+0.83%)

Bristol-Myers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$58.07 /

+0.48 (+0.83%)

BMY Bristol-Myers
$58.07 /

+0.48 (+0.83%)

10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
10/08/21 Morgan Stanley
Bristol-Myers' UC trial miss an incremental negative, says Morgan Stanley
10/08/21 Barclays
Bristol-Myers price target lowered to $68 from $71 at Barclays
09/30/21 Piper Sandler
Acceleron downgraded to Neutral from Overweight at Piper Sandler
BMY Bristol-Myers
$58.07 /

+0.48 (+0.83%)

BMY Bristol-Myers
$58.07 /

+0.48 (+0.83%)

BMY Bristol-Myers
$58.07 /

+0.48 (+0.83%)

BMY Bristol-Myers
$58.07 /

+0.48 (+0.83%)

Hot Stocks
KeyCorp sees Q4 NII down low single digits vs. Q3 » 07:03
10/21/21
10/21
07:03
10/21/21
07:03
KEY

KeyCorp

$23.72 /

+0.52 (+2.24%)

Q3 "relatively…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

10/11/21 Jefferies
KeyCorp price target raised to $27 from $25 at Jefferies
07/19/21 Odeon Capital
KeyCorp downgraded to Hold from Buy at Odeon Capital
07/16/21 Citi
KeyCorp assumed with a Neutral at Citi
07/06/21 Keefe Bruyette
KeyCorp assumed with a Market Perform at Keefe Bruyette
KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

KEY KeyCorp
$23.72 /

+0.52 (+2.24%)

Earnings
Pool Corp. reports Q3 EPS $4.54, consensus $3.85 » 07:03
10/21/21
10/21
07:03
10/21/21
07:03
POOL

Pool Corp.

$463.54 /

-1.06 (-0.23%)

Reports Q3 revenue $1.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

07/23/21 Loop Capital
Pool Corp. price target raised to $485 from $470 at Loop Capital
07/23/21 Baird
Pool Corp. price target raised to $490 from $465 at Baird
06/04/21 Loop Capital
Pool Corp. price target raised to $470 from $440 at Loop Capital
05/18/21
Fly Intel: Top five analyst initiations
POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

POOL Pool Corp.
$463.54 /

-1.06 (-0.23%)

Earnings
Marsh McLennan reports Q3 adjusted EPS $1.08, consensus 98c » 07:03
10/21/21
10/21
07:03
10/21/21
07:03
MMC

Marsh McLennan

$165.68 /

+0.97 (+0.59%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMC Marsh McLennan
$165.68 /

+0.97 (+0.59%)

MMC Marsh McLennan
$165.68 /

+0.97 (+0.59%)

08/16/21 Wolfe Research
Marsh McLennan initiated with an Outperform at Wolfe Research
07/28/21 Raymond James
Marsh McLennan downgraded to Underperform from Market Perform at Raymond James
07/23/21 MKM Partners
Marsh McLennan price target raised to $150 from $140 at MKM Partners
07/23/21 BofA
Marsh McLennan upgraded to Neutral from Underperform at BofA
MMC Marsh McLennan
$165.68 /

+0.97 (+0.59%)

MMC Marsh McLennan
$165.68 /

+0.97 (+0.59%)

MMC Marsh McLennan
$165.68 /

+0.97 (+0.59%)

MMC Marsh McLennan
$165.68 /

+0.97 (+0.59%)

Recommendations
Knight-Swift price target raised to $65 from $57 at Baird » 07:03
10/21/21
10/21
07:03
10/21/21
07:03
KNX

Knight-Swift

$54.33 /

+3.535 (+6.96%)

Baird analyst Garrett…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KNX Knight-Swift
$54.33 /

+3.535 (+6.96%)

KNX Knight-Swift
$54.33 /

+3.535 (+6.96%)

09/15/21
Fly Intel: Top five analyst upgrades
09/15/21 Cowen
Knight-Swift upgraded to Outperform at Cowen on truckers' pricing power
09/15/21 Cowen
Knight-Swift upgraded to Outperform from Market Perform at Cowen
09/10/21 Raymond James
Knight-Swift initiated with an Outperform at Raymond James
KNX Knight-Swift
$54.33 /

+3.535 (+6.96%)

KNX Knight-Swift
$54.33 /

+3.535 (+6.96%)

Hot Stocks
AutoNation board approves additional repurchase of $1B of common stock  07:02
10/21/21
10/21
07:02
10/21/21
07:02
AN

AutoNation

$117.11 /

+1.67 (+1.45%)

 
ShowHide Related Items >><<
AN AutoNation
$117.11 /

+1.67 (+1.45%)

AN AutoNation
$117.11 /

+1.67 (+1.45%)

09/28/21 Morgan Stanley
AutoNation upgraded to Equal Weight from Underweight at Morgan Stanley
07/20/21 Truist
AutoNation price target raised to $110 from $100 at Truist
07/16/21 BofA
AutoNation price target raised to $171 from $161 at BofA
04/22/21
Fly Intel: Top five analyst upgrades
AN AutoNation
$117.11 /

+1.67 (+1.45%)

AN AutoNation
$117.11 /

+1.67 (+1.45%)

Initiation
Baird starts Getty Realty at Outperform with $34 price target » 07:02
10/21/21
10/21
07:02
10/21/21
07:02
GTY

Getty Realty

$31.99 /

+0.72 (+2.30%)

Baird analyst Wesley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTY Getty Realty
$31.99 /

+0.72 (+2.30%)

06:21 Today Baird
Getty Realty initiated with an Outperform at Baird
09/17/21 RBC Capital
Getty Realty initiated with a Sector Perform at RBC Capital
10/22/20 JPMorgan
Getty Realty upgraded to Neutral on 'better footing' at JPMorgan
10/22/20 JPMorgan
Getty Realty upgraded to Neutral from Underweight at JPMorgan
GTY Getty Realty
$31.99 /

+0.72 (+2.30%)

Downgrade
Vale double-downgraded to Underperform from Outperform at RBC Capital » 07:01
10/21/21
10/21
07:01
10/21/21
07:01
VALE

Vale

$13.84 /

-0.37 (-2.60%)

RBC Capital analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VALE Vale
$13.84 /

-0.37 (-2.60%)

VALE Vale
$13.84 /

-0.37 (-2.60%)

06:56 Today RBC Capital
Vale downgraded to Underperform from Outperform at RBC Capital
10/20/21 Jefferies
Jefferies downgrades trio of iron ore miners on near-term downside risk
10/20/21 Jefferies
Vale downgraded to Hold from Buy at Jefferies
10/07/21 BMO Capital
Wheaton Precious Metals price target lowered to $52 from $53 at BMO Capital
VALE Vale
$13.84 /

-0.37 (-2.60%)

VALE Vale
$13.84 /

-0.37 (-2.60%)

VALE Vale
$13.84 /

-0.37 (-2.60%)

Earnings
AutoNation reports Q3 EPS $5.12, consensus $4.20 » 07:01
10/21/21
10/21
07:01
10/21/21
07:01
AN

AutoNation

$117.11 /

+1.67 (+1.45%)

Reports Q3 revenue $6.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AN AutoNation
$117.11 /

+1.67 (+1.45%)

AN AutoNation
$117.11 /

+1.67 (+1.45%)

09/28/21 Morgan Stanley
AutoNation upgraded to Equal Weight from Underweight at Morgan Stanley
07/20/21 Truist
AutoNation price target raised to $110 from $100 at Truist
07/16/21 BofA
AutoNation price target raised to $171 from $161 at BofA
04/22/21
Fly Intel: Top five analyst upgrades
AN AutoNation
$117.11 /

+1.67 (+1.45%)

AN AutoNation
$117.11 /

+1.67 (+1.45%)

Earnings
Blackstone reports Q3 distributable EPS $1.28, consensus 91c » 07:00
10/21/21
10/21
07:00
10/21/21
07:00
BX

Blackstone

$128.85 /

+2.02 (+1.59%)

Reports Q3 revenue $6.22B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BX Blackstone
$128.85 /

+2.02 (+1.59%)

BX Blackstone
$128.85 /

+2.02 (+1.59%)

10/07/21 Jefferies
KKR resumed with a Buy at Jefferies
09/13/21
Fly Intel: Top five analyst upgrades
09/13/21 BMO Capital
Carlyle Group upgraded to Outperform from Market Perform at BMO Capital
09/03/21 Evercore ISI
Gates Industrial initiated with an Outperform at Evercore ISI
BX Blackstone
$128.85 /

+2.02 (+1.59%)

BX Blackstone
$128.85 /

+2.02 (+1.59%)

BX Blackstone
$128.85 /

+2.02 (+1.59%)

BX Blackstone
$128.85 /

+2.02 (+1.59%)

Recommendations
CSX price target raised to $38 from $36 at Baird » 07:00
10/21/21
10/21
07:00
10/21/21
07:00
CSX

CSX

$34.44 /

+0.34 (+1.00%)

Baird analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSX CSX
$34.44 /

+0.34 (+1.00%)

CSX CSX
$34.44 /

+0.34 (+1.00%)

06:13 Today Citi
CSX price target raised to $42 from $38 at Citi
09/17/21 RBC Capital
CSX cut to Sector Perform at RBC Capital on supply chain congestion
09/17/21 RBC Capital
CSX downgraded to Sector Perform from Outperform at RBC Capital
07/22/21
Fly Intel: Top five analyst upgrades
CSX CSX
$34.44 /

+0.34 (+1.00%)

CSX CSX
$34.44 /

+0.34 (+1.00%)

CSX CSX
$34.44 /

+0.34 (+1.00%)

CSX CSX
$34.44 /

+0.34 (+1.00%)

Recommendations
Stephens remains buyer of Brinker, sees shares at trough » 06:59
10/21/21
10/21
06:59
10/21/21
06:59
EAT

Brinker

$44.24 /

-4.68 (-9.57%)

Stephens analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EAT Brinker
$44.24 /

-4.68 (-9.57%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

10/19/21 Stephens
Brinker margin miss even larger than expected, says Stephens
10/18/21 KeyBanc
Brinker price target lowered to $58 from $63 at KeyBanc
10/14/21 Barclays
Brinker price target lowered to $55 from $60 at Barclays
09/28/21 OTR Global
Brinker view downgraded to Mixed from Positive at OTR Global
EAT Brinker
$44.24 /

-4.68 (-9.57%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

EAT Brinker
$44.24 /

-4.68 (-9.57%)

Hot Stocks
Geo Group signs new correctional facility lease agreement with New Mexico » 06:59
10/21/21
10/21
06:59
10/21/21
06:59
GEO

Geo Group

$8.23 /

-0.14 (-1.67%)

Geo Group has entered…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GEO Geo Group
$8.23 /

-0.14 (-1.67%)

GEO Geo Group
$8.23 /

-0.14 (-1.67%)

06/08/21 Wedbush
Wedbush sees Geo Group facing two major headwinds, initiates with Neutral
06/08/21 Wedbush
Geo Group initiated with a Neutral at Wedbush
GEO Geo Group
$8.23 /

-0.14 (-1.67%)

GEO Geo Group
$8.23 /

-0.14 (-1.67%)

GEO Geo Group
$8.23 /

-0.14 (-1.67%)

GEO Geo Group
$8.23 /

-0.14 (-1.67%)

Earnings
Quest Diagnostics ups FY21 adjusted EPS view to $13.50-$13.90 from $11.65-$12.35 » 06:58
10/21/21
10/21
06:58
10/21/21
06:58
DGX

Quest Diagnostics

$146.91 /

+1.22 (+0.84%)

Consensus $11.93, Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

10/19/21 Citi
Citi opens 'Positive Catalyst watches' on Quest, LabCorp
09/10/21 Citi
Quest Diagnostics price target raised to $181 from $158 at Citi
09/09/21 Credit Suisse
Quest guidance raised on higher Covid test volumes, says Credit Suisse
09/01/21 KeyBanc
Quest Diagnostics price target raised to $168 from $144 at KeyBanc
DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

Hot Stocks
MediciNova's MN-001 featured in abstract at ISA2021 » 06:56
10/21/21
10/21
06:56
10/21/21
06:56
MNOV

MediciNova

$3.80 /

+0.04 (+1.06%)

MediciNova announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNOV MediciNova
$3.80 /

+0.04 (+1.06%)

MNOV MediciNova
$3.80 /

+0.04 (+1.06%)

03/10/21
Fly Intel: Top five analyst initiations
03/10/21 Maxim
MediciNova initiated with a Buy at Maxim
03/10/21 Maxim
MediciNova initiated with a Buy at Maxim
MNOV MediciNova
$3.80 /

+0.04 (+1.06%)

MNOV MediciNova
$3.80 /

+0.04 (+1.06%)

Downgrade
Vale downgraded to Underperform from Outperform at RBC Capital » 06:56
10/21/21
10/21
06:56
10/21/21
06:56
VALE

Vale

$13.84 /

-0.37 (-2.60%)

RBC Capital analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VALE Vale
$13.84 /

-0.37 (-2.60%)

VALE Vale
$13.84 /

-0.37 (-2.60%)

10/20/21 Jefferies
Jefferies downgrades trio of iron ore miners on near-term downside risk
10/20/21 Jefferies
Vale downgraded to Hold from Buy at Jefferies
10/07/21 BMO Capital
Wheaton Precious Metals price target lowered to $52 from $53 at BMO Capital
10/06/21 Exane BNP Paribas
Vale upgraded to Neutral from Underperform at Exane BNP Paribas
VALE Vale
$13.84 /

-0.37 (-2.60%)

VALE Vale
$13.84 /

-0.37 (-2.60%)

VALE Vale
$13.84 /

-0.37 (-2.60%)

Earnings
Quest Diagnostics reports Q3 adjusted EPS $3.96, consensus $2.87 » 06:55
10/21/21
10/21
06:55
10/21/21
06:55
DGX

Quest Diagnostics

$146.91 /

+1.22 (+0.84%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

10/19/21 Citi
Citi opens 'Positive Catalyst watches' on Quest, LabCorp
09/10/21 Citi
Quest Diagnostics price target raised to $181 from $158 at Citi
09/09/21 Credit Suisse
Quest guidance raised on higher Covid test volumes, says Credit Suisse
09/01/21 KeyBanc
Quest Diagnostics price target raised to $168 from $144 at KeyBanc
DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

DGX Quest Diagnostics
$146.91 /

+1.22 (+0.84%)

Recommendations
Biogen, Roche calls 'not helpful for Ionis story,' says Benchmark » 06:54
10/21/21
10/21
06:54
10/21/21
06:54
IONS

Ionis Pharmaceuticals

$30.53 /

-0.73 (-2.34%)

, BIIB

Biogen

$266.28 /

-1.53 (-0.57%)

, RHHBY

Roche

$47.76 /

-0.79 (-1.63%)

Benchmark analyst Aydin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$30.53 /

-0.73 (-2.34%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

RHHBY Roche
$47.76 /

-0.79 (-1.63%)

IONS Ionis Pharmaceuticals
$30.53 /

-0.73 (-2.34%)

07/15/21 Canaccord
Bicycle Therapeutics price target raised to $40 from $36 at Canaccord
07/14/21 Benchmark
Bicycle deal 'makes little sense' for Ionis, says Benchmark
07/13/21 William Blair
Bicycle collaboration a positive for Ionis, says William Blair
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
BIIB Biogen
$266.28 /

-1.53 (-0.57%)

10/20/21 Piper Sandler
Biogen price target lowered to $390 from $460 at Piper Sandler
10/20/21 Piper Sandler
Biogen's Aduhelm launch 'even worse than feared,' says Piper Sandler
10/17/21 Piper Sandler
Piper Sandler remains bullish on Biogen despite mixed VALOR study update
10/15/21 Cantor Fitzgerald
Biogen price target lowered to $327 from $427 at Cantor Fitzgerald
RHHBY Roche
$47.76 /

-0.79 (-1.63%)

10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
IONS Ionis Pharmaceuticals
$30.53 /

-0.73 (-2.34%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

RHHBY Roche
$47.76 /

-0.79 (-1.63%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

RHHBY Roche
$47.76 /

-0.79 (-1.63%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

RHHBY Roche
$47.76 /

-0.79 (-1.63%)

BIIB Biogen
$266.28 /

-1.53 (-0.57%)

Earnings
Lindsay reports Q4 EPS 53c with items, consensus 79c » 06:54
10/21/21
10/21
06:54
10/21/21
06:54
LNN

Lindsay

$159.51 /

-2.485 (-1.53%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LNN Lindsay
$159.51 /

-2.485 (-1.53%)

LNN Lindsay
$159.51 /

-2.485 (-1.53%)

10/23/20
Fly Intel: Top five analyst upgrades
10/23/20 Monness Crespi
Lindsay upgraded to Neutral from Sell at Monness Crespi
10/22/20 Boenning & Scattergood
Lindsay upgraded to Outperform from Neutral at Boenning & Scattergood
LNN Lindsay
$159.51 /

-2.485 (-1.53%)

Earnings
Southwest sees Q4 revenue down 15%-25%, consensus $4.76B » 06:54
10/21/21
10/21
06:54
10/21/21
06:54
LUV

Southwest

$49.48 /

+0.11 (+0.22%)

Sees Q4 load factor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LUV Southwest
$49.48 /

+0.11 (+0.22%)

LUV Southwest
$49.48 /

+0.11 (+0.22%)

10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/04/21
Fly Intel: Top five analyst upgrades
10/04/21 Barclays
Southwest upgraded to Overweight from Equal Weight at Barclays
10/01/21
Fly Intel: Top five analyst upgrades
LUV Southwest
$49.48 /

+0.11 (+0.22%)

LUV Southwest
$49.48 /

+0.11 (+0.22%)

LUV Southwest
$49.48 /

+0.11 (+0.22%)

LUV Southwest
$49.48 /

+0.11 (+0.22%)

Earnings
Lottery.com sees Q3 revenue up 35% sequentially to $22M-$24M  06:53
10/21/21
10/21
06:53
10/21/21
06:53
LTRY

Lottery.com

/

+

 
ShowHide Related Items >><<
LTRY Lottery.com
/

+

LTRY Lottery.com
/

+

09/21/21 Northland
Trident Acquisitions Corp. initiated with an Outperform at Northland
LTRY Lottery.com
/

+

Recommendations
Marqeta price target lowered to $25 from $29 at Mizuho » 06:52
10/21/21
10/21
06:52
10/21/21
06:52
MQ

Marqeta

$27.48 /

+2.87 (+11.66%)

Mizuho analyst Dan Dolev…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MQ Marqeta
$27.48 /

+2.87 (+11.66%)

MQ Marqeta
$27.48 /

+2.87 (+11.66%)

08/19/21 Truist
ValueAct's reported SOTP argument for Fiserv 'doesn't hold water,' says Truist
08/18/21
Fly Intel: Top five analyst initiations
08/18/21 Truist
Truist starts Marqeta at Buy on next-gen vCard solutions success
08/18/21 Truist
Marqeta initiated with a Buy at Truist
  • 09
    Jun
MQ Marqeta
$27.48 /

+2.87 (+11.66%)

MQ Marqeta
$27.48 /

+2.87 (+11.66%)

MQ Marqeta
$27.48 /

+2.87 (+11.66%)

Recommendations
Affirm price target raised to $170 from $150 at Mizuho » 06:52
10/21/21
10/21
06:52
10/21/21
06:52
AFRM

Affirm

$147.76 /

-7.49 (-4.82%)

Mizuho analyst Dan Dolev…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AFRM Affirm
$147.76 /

-7.49 (-4.82%)

AFRM Affirm
$147.76 /

-7.49 (-4.82%)

06:20 Today Barclays
Affirm price target raised to $175 from $140 at Barclays
10/06/21 Morgan Stanley
Affirm relationship with Target not new, says Morgan Stanley
09/30/21 Jefferies
Zip Co. downgraded to Hold from Buy at Jefferies
09/29/21 Jefferies
Affirm price target raised to $110 from $82 at Jefferies
AFRM Affirm
$147.76 /

-7.49 (-4.82%)

  • 13
    Jan
AFRM Affirm
$147.76 /

-7.49 (-4.82%)

AFRM Affirm
$147.76 /

-7.49 (-4.82%)

AFRM Affirm
$147.76 /

-7.49 (-4.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.